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(N[205)Balloon sized
(N: 95)MDCT sized
(N: 110) P-valueComposite
sizing-
complication,
N (%)29 (14.1) 14 (14.7) 15 (13.9) 0.82Post BAV
instability, N
(%)2 (1.0) 2 (2.1) 0 (0.0) 0.21Major vascular
complication,
N (%)7 (3.4) 1 (1.1) 6 (5.5) 0.13Tamponade, N
(%)4 (2.0) 2 (2.1) 2 (1.8) 1.0Annular rupture,
N (%)3 (1.5) 1 (1.1) 2 (1.8) 1.0Heart block
requiring new
ppm, N (%)14 (6.8) 7 (7.4) 7 (6.4) 0.78Postoperative
acute renal
failure, N (%)4 (2.0) 3 (3.2) 1 (0.9) 0.34Minor stroke, N
(%)1 (1.1) 0 (0.0) 1 (0.9) 1.0Major stroke, N
(%)1 (1.1) 0 (0.0) 1 (0.9) 1.030-Day
Readmissions,
N (%)13 (6.3) 6 (6.3) 7 (6.4) 1.030-day
Mortality, N
(%)3 (1.5) 1 (1.1) 2 (1.8) 1.0Angiography
paravalvular
leak, N (%)0.57*None 128 (62.4) 57 (60.0) 71 (64.5)Mild or greater 77 (37.6) 38 (40.0) 39 (35.5)Aortic
regurgitation
index, N (%)0.01*<25 68 (36.2) 23 (25.6) 45 (45.9)25 120 (53.8) 67 (74.4) 53 (54.1)
30-day
paravalvular
leak, N (%)0.78*None 129 (65.5) 54 (59.3) 75 (70.8)Mild or greater 68 (34.5) 37 (40.7) 31 (29.3)BAV ¼ Balloon Aortic Valvuloplasty, CPR ¼ cardiopulmonary resuscitation, ppm ¼ permanent pace-
maker.*Adjusted for valve type, size, access and aortic valve calciﬁcation
CONCLUSIONS In those patients in which optimal valve size remains
questionable, intraoperative balloon sizing is a safe procedure that
complements MDCT for annular sizing prior to TAVR.
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BACKGROUND Screening for internal carotid artery stenosis (ICAS)
with Doppler ultrasound is commonly used before cardiac surgery.
However, the relationship between ICAS and procedure-related stroke
in aortic valve replacement is unclear.METHODS We retrospectively reviewed patients with severe AS who
underwent doppler carotid screening before surgical (SAVR) or trans-
catheter aortic valve replacement (TAVR) with a balloon-expandable
valve between 1/2007 and 8/2014. Logistic regressionmodelswere used
to determine the relation between 30-day post-procedure stroke and
total (sum of left and right ICAS) and maximal unilateral ICAS. The
model was adjusted for age, gender, history of atrial ﬁbrillation, prior
cerebrovascular disease and diabetes, left ventricular ejection fraction,
and procedure type. 11 patients who underwent carotid intervention
before valve replacementwere excluded from the logisticmodels. Two-
subgroup analyses were performed in patients that underwent TAVR
and SAVR further adjusting for procedure speciﬁc details.
RESULTS 991 patients underwent ICAS screening prior to TAVR
(n¼467) or SAVR (n¼529). In the entire group, the prevalence of 70%
asymptomatic ICAS was 4.9% (n¼49) and incidence of 30-day stroke
was 3.4% (n¼34). We did not ﬁnd an association between stroke and
either the total or maximal unilateral ICAS in our adjusted analysis for
all patients (p¼0.09 and p¼0.31). There was no difference between
those patients that underwent TAVR (p¼0.15 and 0¼0.44) or SAVR
(p¼0.30 and p¼0.49, Figure 1)
CONCLUSIONS The incidence of signiﬁcant ICAS in preoperative
screening for TAVR or SAVR is uncommon. Our study suggests that
ICAS plays little or no role in the occurrence of procedure-related
stroke after aortic valve replacement. Arguing against routine carotid
Doppler screening before isolated TAVR or SAVR.
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BACKGROUND Moderate or severe aortic regurgitation (AR) in pa-
tients with severe aortic stenosis (AS) undergoing transcatheter aortic
valve replacement (TAVR) may adversely impact clinical outcomes.
One of the modalities used to reduce residual AR is to implant a sec-
ond device in the same procedure. This study details the results and
outcome of patients who underwent a second CoreValve (CV) im-
plantation to treat residual AR following the initial CV placement.
METHODS Patients with severe AS treated with CV device who had mod-
erate or severe AR underwent optimized balloon sizing post dilation but
continued to have signiﬁcant residual AR post BAV and were subjected to a
